9 | hematocrit | Crl:CD(SD) | female | 45.3889 | % | naive control condition (for 14 days) | 59854 | naive control condition (for 14 days) |

7 | hematocrit | F344/DuCrl | male | 47.4143 | % | naive control condition (for 14 days) | 59853 | naive control condition (for 14 days) |

9 | hematocrit | Crl:CD(SD) | male | 44.7 | % | naive control condition (for 14 days) | 59852 | naive control condition (for 14 days) |

10 | hematocrit | LEW/Crl | female | 48.31 | % | naive control condition (for 14 days) | 59851 | naive control condition (for 14 days) |

9 | hematocrit | WKY/NCrl | male | 44.5222 | % | naive control condition (for 14 days) | 59850 | naive control condition (for 14 days) |

14 | hematocrit | FHH-Chr 1BN/Mcwi | female | 46.2857 | % | naive control condition (for 14 days) | 57564 | naive control condition (for 14 days) |

8 | hematocrit | SS-Chr 2BN/Mcwi | male | 45.4375 | % | naive control condition (for 14 days) | 57563 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 9BN/Mcwi | male | 37.8625 | % | naive control condition (for 14 days) | 57562 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr 7BN/Mcwi | male | 41.9 | % | naive control condition (for 14 days) | 57561 | naive control condition (for 14 days) |

8 | hematocrit | SS-Chr XBN/Mcwi | male | 44.55 | % | naive control condition (for 14 days) | 57560 | naive control condition (for 14 days) |

11 | hematocrit | BN/NHsdMcwi | female | 44.0364 | % | naive control condition (for 14 days) | 57559 | naive control condition (for 14 days) |

18 | hematocrit | BN/NHsdMcwi | male | 45.1889 | % | naive control condition (for 14 days) | 57558 | naive control condition (for 14 days) |

8 | hematocrit | SS-Chr 12BN/Mcwi | female | 40.9375 | % | naive control condition (for 14 days) | 57557 | naive control condition (for 14 days) |

17 | hematocrit | SS.BN-(D8Rat163-D8Rat81)/Mcwi | male | 46.9294 | % | naive control condition (for 14 days) | 57556 | naive control condition (for 14 days) |

11 | hematocrit | SS-Chr 2BN/Mcwi | female | 45.8273 | % | naive control condition (for 14 days) | 57555 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 9BN/Mcwi | female | 37.6375 | % | naive control condition (for 14 days) | 57554 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr 7BN/Mcwi | female | 41.4222 | % | naive control condition (for 14 days) | 57553 | naive control condition (for 14 days) |

7 | hematocrit | SS-Chr 19BN/Mcwi | female | 42.4857 | % | naive control condition (for 14 days) | 57552 | naive control condition (for 14 days) |

15 | hematocrit | SS-Chr 4BN/Mcwi | female | 43.8867 | % | naive control condition (for 14 days) | 57551 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 11BN/Mcwi | female | 42.7 | % | naive control condition (for 14 days) | 57550 | naive control condition (for 14 days) |

10 | hematocrit | SS-Chr 12BN/Mcwi | male | 40.1 | % | naive control condition (for 14 days) | 57549 | naive control condition (for 14 days) |

7 | hematocrit | SS-Chr 19BN/Mcwi | male | 42.0571 | % | naive control condition (for 14 days) | 57548 | naive control condition (for 14 days) |

11 | hematocrit | SS.BN-(D8Rat163-D8Rat81)/Mcwi | female | 47.6818 | % | naive control condition (for 14 days) | 57547 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr 4BN/Mcwi | female | 41.4111 | % | naive control condition (for 14 days) | 57546 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 11BN/Mcwi | male | 44.55 | % | naive control condition (for 14 days) | 57545 | naive control condition (for 14 days) |

12 | hematocrit | SS/JrHsdMcwi | female | 46.1333 | % | naive control condition (for 14 days) | 57544 | naive control condition (for 14 days) |

12 | hematocrit | SS-Chr 4BN/Mcwi | male | 43.675 | % | naive control condition (for 14 days) | 57543 | naive control condition (for 14 days) |

7 | hematocrit | SS-Chr 1BN/Mcwi | female | 41.6429 | % | naive control condition (for 14 days) | 57542 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr 4BN/Mcwi | male | 41.9222 | % | naive control condition (for 14 days) | 57541 | naive control condition (for 14 days) |

10 | hematocrit | SS-Chr 18BN/Mcwi | female | 47.4 | % | naive control condition (for 14 days) | 57540 | naive control condition (for 14 days) |

12 | hematocrit | FHH-Chr 1BN/Mcwi | male | 46.9583 | % | naive control condition (for 14 days) | 57539 | naive control condition (for 14 days) |

8 | hematocrit | SS-Chr XBN/Mcwi | female | 44.25 | % | naive control condition (for 14 days) | 57538 | naive control condition (for 14 days) |

6 | hematocrit | SS-Chr 1BN/Mcwi | male | 42.7 | % | naive control condition (for 14 days) | 57537 | naive control condition (for 14 days) |

87 | hematocrit | SS/JrHsdMcwi | male | 44.5149 | % | naive control condition (for 14 days) | 57536 | naive control condition (for 14 days) |

9 | hematocrit | SS-Chr 18BN/Mcwi | male | 46.1889 | % | naive control condition (for 14 days) | 57535 | naive control condition (for 14 days) |

13 | hematocrit | SS-Chr 11BN/Mcwi | male | 43.8846 | % | naive control condition (for 14 days) | 57534 | naive control condition (for 14 days) |

20 | hematocrit | SS-Chr YBN/Mcwi | male | 45.72 | % | naive control condition (for 14 days) | 57533 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr YBN/Mcwi | male | 38.5889 | % | naive control condition (for 14 days) | 57532 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 3BN/Mcwi | male | 40.9375 | % | naive control condition (for 14 days) | 57531 | naive control condition (for 14 days) |

11 | hematocrit | SS-Chr 13BN/Mcwi | male | 43.2545 | % | naive control condition (for 14 days) | 57530 | naive control condition (for 14 days) |

48 | hematocrit | FHH/EurMcwi | male | 43.4688 | % | naive control condition (for 14 days) | 57529 | naive control condition (for 14 days) |

12 | hematocrit | SS-Chr 11BN/Mcwi | female | 44.4 | % | naive control condition (for 14 days) | 57528 | naive control condition (for 14 days) |

10 | hematocrit | FHH-Chr 18BN/Mcwi | female | 43.53 | % | naive control condition (for 14 days) | 57527 | naive control condition (for 14 days) |

22 | hematocrit | SS-Chr 20BN/Mcwi | male | 43.9955 | % | naive control condition (for 14 days) | 57526 | naive control condition (for 14 days) |

13 | hematocrit | FHH-Chr 20BN/Mcwi | female | 42.5846 | % | naive control condition (for 14 days) | 57525 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr 18BN/Mcwi | male | 43.6333 | % | naive control condition (for 14 days) | 57524 | naive control condition (for 14 days) |

13 | hematocrit | FHH-Chr 20BN/Mcwi | male | 41.3154 | % | naive control condition (for 14 days) | 57523 | naive control condition (for 14 days) |

10 | hematocrit | FHH-Chr 13BN/Mcwi | male | 42.92 | % | naive control condition (for 14 days) | 57522 | naive control condition (for 14 days) |

11 | hematocrit | SS-Chr 13BN/Mcwi | female | 43.4818 | % | naive control condition (for 14 days) | 57521 | naive control condition (for 14 days) |

10 | hematocrit | SS-Chr 3BN/Mcwi | female | 41.76 | % | naive control condition (for 14 days) | 57520 | naive control condition (for 14 days) |

10 | hematocrit | FHH-Chr 8BN/Mcwi | male | 43.8 | % | naive control condition (for 14 days) | 57519 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr 13BN/Mcwi | female | 40.5444 | % | naive control condition (for 14 days) | 57518 | naive control condition (for 14 days) |

6 | hematocrit | SS-Chr 16BN/Mcwi | male | 44.0333 | % | naive control condition (for 14 days) | 57517 | naive control condition (for 14 days) |

7 | hematocrit | FHH-Chr 19BN/Mcwi | female | 40.1571 | % | naive control condition (for 14 days) | 57516 | naive control condition (for 14 days) |

10 | hematocrit | SS-Chr 15BN/Mcwi | female | 44.16 | % | naive control condition (for 14 days) | 57515 | naive control condition (for 14 days) |

10 | hematocrit | SS-Chr 3BN/Mcwi | male | 42.57 | % | naive control condition (for 14 days) | 57514 | naive control condition (for 14 days) |

10 | hematocrit | SS-Chr 15BN/Mcwi | male | 43.74 | % | naive control condition (for 14 days) | 57513 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 3BN/Mcwi | female | 39.725 | % | naive control condition (for 14 days) | 57512 | naive control condition (for 14 days) |

7 | hematocrit | SS-Chr 16BN/Mcwi | female | 45.3429 | % | naive control condition (for 14 days) | 57511 | naive control condition (for 14 days) |

14 | hematocrit | FHH/EurMcwi | female | 44.3714 | % | naive control condition (for 14 days) | 57510 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 19BN/Mcwi | male | 40.1875 | % | naive control condition (for 14 days) | 57509 | naive control condition (for 14 days) |

21 | hematocrit | SS-Chr 20BN/Mcwi | female | 44.5714 | % | naive control condition (for 14 days) | 57508 | naive control condition (for 14 days) |

10 | hematocrit | FHH-Chr 8BN/Mcwi | female | 40.77 | % | naive control condition (for 14 days) | 57507 | naive control condition (for 14 days) |

10 | hematocrit | FHH-Chr 16BN/Mcwi | male | 43.28 | % | naive control condition (for 14 days) | 57506 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr XBN/Mcwi | female | 38.15 | % | naive control condition (for 14 days) | 57505 | naive control condition (for 14 days) |

10 | hematocrit | FHH-Chr 10BN/Mcwi | male | 37.81 | % | naive control condition (for 14 days) | 57504 | naive control condition (for 14 days) |

8 | hematocrit | SS-Chr 5BN/Mcwi | male | 40.575 | % | naive control condition (for 14 days) | 57503 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr XBN/Mcwi | male | 42.225 | % | naive control condition (for 14 days) | 57502 | naive control condition (for 14 days) |

11 | hematocrit | SS-Chr 7BN/Mcwi | female | 43.8364 | % | naive control condition (for 14 days) | 57501 | naive control condition (for 14 days) |

4 | hematocrit | GH/OmrMcwi | male | 48.725 | % | naive control condition (for 14 days) | 57500 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr 17BN/Mcwi | female | 39.7667 | % | naive control condition (for 14 days) | 57499 | naive control condition (for 14 days) |

7 | hematocrit | SS-Chr 5BN/Mcwi | female | 40.7429 | % | naive control condition (for 14 days) | 57498 | naive control condition (for 14 days) |

12 | hematocrit | SS-Chr 17BN/Mcwi | female | 42.3333 | % | naive control condition (for 14 days) | 57497 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr 17BN/Mcwi | male | 41.3 | % | naive control condition (for 14 days) | 57496 | naive control condition (for 14 days) |

5 | hematocrit | GH/OmrMcwi | female | 48.26 | % | naive control condition (for 14 days) | 57495 | naive control condition (for 14 days) |

11 | hematocrit | SS-Chr 7BN/Mcwi | male | 45.1818 | % | naive control condition (for 14 days) | 57494 | naive control condition (for 14 days) |

9 | hematocrit | FHH-Chr 16BN/Mcwi | female | 43.3 | % | naive control condition (for 14 days) | 57493 | naive control condition (for 14 days) |

7 | hematocrit | FHH-Chr 10BN/Mcwi | female | 36.3571 | % | naive control condition (for 14 days) | 57492 | naive control condition (for 14 days) |

11 | hematocrit | SS-Chr 17BN/Mcwi | male | 40.6455 | % | naive control condition (for 14 days) | 57491 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 2BN/Mcwi | male | 42.4375 | % | naive control condition (for 14 days) | 57490 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 14BN/Mcwi | male | 40.2 | % | naive control condition (for 14 days) | 57489 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 15BN/Mcwi | female | 41.1625 | % | naive control condition (for 14 days) | 57488 | naive control condition (for 14 days) |

13 | hematocrit | SS-Chr 10BN/Mcwi | female | 42.8231 | % | naive control condition (for 14 days) | 57487 | naive control condition (for 14 days) |

12 | hematocrit | FHH-Chr 12BN/Mcwi | male | 43.7333 | % | naive control condition (for 14 days) | 57486 | naive control condition (for 14 days) |

9 | hematocrit | SS-Chr 6BN/Mcwi | male | 44.4556 | % | naive control condition (for 14 days) | 57485 | naive control condition (for 14 days) |

9 | hematocrit | SS-Chr 9BN/Mcwi | female | 46.4333 | % | naive control condition (for 14 days) | 57484 | naive control condition (for 14 days) |

10 | hematocrit | SS-Chr 14BN/Mcwi | male | 42.22 | % | naive control condition (for 14 days) | 57483 | naive control condition (for 14 days) |

7 | hematocrit | FHH-Chr 5BN/Mcwi | male | 42.1429 | % | naive control condition (for 14 days) | 57482 | naive control condition (for 14 days) |

10 | hematocrit | FHH-Chr 6BN/Mcwi | female | 39.65 | % | naive control condition (for 14 days) | 57481 | naive control condition (for 14 days) |

10 | hematocrit | SS.BN-(D12Arb13-D12Rat79)/Mcwi | female | 43.99 | % | naive control condition (for 14 days) | 57480 | naive control condition (for 14 days) |

9 | hematocrit | SS-Chr 9BN/Mcwi | male | 45 | % | naive control condition (for 14 days) | 57479 | naive control condition (for 14 days) |

10 | hematocrit | SS-Chr 6BN/Mcwi | female | 44.47 | % | naive control condition (for 14 days) | 57478 | naive control condition (for 14 days) |

10 | hematocrit | FHH-Chr 6BN/Mcwi | male | 42.98 | % | naive control condition (for 14 days) | 57477 | naive control condition (for 14 days) |

10 | hematocrit | SS-Chr 14BN/Mcwi | female | 42.54 | % | naive control condition (for 14 days) | 57476 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 5BN/Mcwi | female | 40.5 | % | naive control condition (for 14 days) | 57475 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 2BN/Mcwi | female | 39.5125 | % | naive control condition (for 14 days) | 57474 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 14BN/Mcwi | female | 39.7375 | % | naive control condition (for 14 days) | 57473 | naive control condition (for 14 days) |

10 | hematocrit | SS.BN-(D12Arb13-D12Rat79)/Mcwi | male | 45.66 | % | naive control condition (for 14 days) | 57472 | naive control condition (for 14 days) |

15 | hematocrit | SS-Chr 10BN/Mcwi | male | 40.68 | % | naive control condition (for 14 days) | 57471 | naive control condition (for 14 days) |

11 | hematocrit | FHH-Chr 12BN/Mcwi | female | 42.4273 | % | naive control condition (for 14 days) | 57470 | naive control condition (for 14 days) |

8 | hematocrit | FHH-Chr 15BN/Mcwi | male | 42.7 | % | naive control condition (for 14 days) | 57469 | naive control condition (for 14 days) |

9 | hematocrit | GH/OmrMcwi | male | 49.4889 | % | naive control condition (for 14 days) | 60127 | naive control condition (for 14 days) |

11 | hematocrit | SHR/NCrl | male | 47.7636 | % | naive control condition (for 14 days) | 60126 | naive control condition (for 14 days) |

19 | hematocrit | SS/JrHsdMcwi | female | 45.6211 | % | naive control condition (for 14 days) | 60125 | naive control condition (for 14 days) |

7 | hematocrit | FHH/EurMcwi | male | 47.2286 | % | naive control condition (for 14 days) | 60124 | naive control condition (for 14 days) |

5 | hematocrit | SS-Chr 16BN/Mcwi | male | 48.8 | % | naive control condition (for 14 days) | 60123 | naive control condition (for 14 days) |

9 | hematocrit | GH/OmrMcwi | female | 47.9333 | % | naive control condition (for 14 days) | 60122 | naive control condition (for 14 days) |

9 | hematocrit | SS-Chr 18BN/Mcwi | female | 45.8778 | % | naive control condition (for 14 days) | 60121 | naive control condition (for 14 days) |

10 | hematocrit | SHR/NCrl | female | 44.27 | % | naive control condition (for 14 days) | 60120 | naive control condition (for 14 days) |

6 | hematocrit | SS-Chr 16BN/Mcwi | female | 47.8333 | % | naive control condition (for 14 days) | 60119 | naive control condition (for 14 days) |

8 | hematocrit | FHH/EurMcwi | female | 47.425 | % | naive control condition (for 14 days) | 60118 | naive control condition (for 14 days) |

20 | hematocrit | SS/JrHsdMcwi | male | 44.77 | % | naive control condition (for 14 days) | 60117 | naive control condition (for 14 days) |

8 | hematocrit | SS-Chr 18BN/Mcwi | male | 46.475 | % | naive control condition (for 14 days) | 60116 | naive control condition (for 14 days) |

8 | hematocrit | Hsd:SD | female | 45.7 | % | naive control condition (for 14 days) | 60073 | naive control condition (for 14 days) |

8 | hematocrit | Hsd:SD | male | 45.95 | % | naive control condition (for 14 days) | 60072 | naive control condition (for 14 days) |

13 | hematocrit | LE/BluGill | male | 45.8308 | % | naive control condition (for 14 days) | 59859 | naive control condition (for 14 days) |

16 | hematocrit | F344/DuCrl | female | 47.8125 | % | naive control condition (for 14 days) | 59858 | naive control condition (for 14 days) |

11 | hematocrit | WKY/NCrl | female | 44.3182 | % | naive control condition (for 14 days) | 59857 | naive control condition (for 14 days) |

9 | hematocrit | LEW/Crl | male | 46.6778 | % | naive control condition (for 14 days) | 59856 | naive control condition (for 14 days) |

13 | hematocrit | LE/BluGill | female | 45.8385 | % | naive control condition (for 14 days) | 59855 | naive control condition (for 14 days) |

6 | hematocrit | SS-Chr 16BN/Mcwi | male | 46.7667 | % | naive control condition (for 14 days) | 58858 | naive control condition (for 14 days) |

7 | hematocrit | SS-Chr 16BN/Mcwi | female | 45.6429 | % | naive control condition (for 14 days) | 58857 | naive control condition (for 14 days) |

4 | hematocrit | SS/JrHsdMcwi | male | 46.275 | % | naive control condition (for 14 days) | 58856 | naive control condition (for 14 days) |